CSF gentamicin level of 1-2 mg/l (range 0 2-2 9) after intramuscular administration of 1-5-2-5 mg/kg. The same authors measured 2-6 mg gentamicin/l (range 2.5-2.7) in CSF 24 hours after an intrathecal dose of 0 5 mg, and 15-8 mg/l (range 4 3-60) after an intraventricular dose of 0 5-1 mg. CSF levels of gentamicin up to 7 mg/l were obtained by Newman and Holt (1967) after 1-2 mg/kg per day intramuscularly and 0 2-1 mg/day intraventricularly.
4.5 mM calcium chloride correlated well with that from standards made up in cerebrospinal fluid. There was no evidence of gentamicin being bound to protein in the cerebrospinal fluid.
Over 50% of the instances of meningitis in neonates are caused by Gram-negative enteric bacilli (Mathies et al, 1971) . Gentamicin, being effective against these organisms, is a useful agent in the treatment of meningitis in the newborn.
Systemic administration of gentamicin does not give rise to adequate therapeutic levels in the cerebrospinal fluid. Riff and Jackson (1971) could not detect measurable levels in the CSF after intramuscular injection unless the serum level exceeded 4 mg/I. McCracken et al (1971) reported a mean CSF gentamicin level of 1-2 mg/l (range 0 2-2 9) after intramuscular administration of 1-5-2-5 mg/kg. The same authors measured 2-6 mg gentamicin/l (range 2.5-2.7) in CSF 24 hours after an intrathecal dose of 0 5 mg, and 15-8 mg/l (range 4 3-60) after an intraventricular dose of 0 5-1 mg. CSF levels of gentamicin up to 7 mg/l were obtained by Newman and Holt (1967) after 1-2 mg/kg per day intramuscularly and 0 2-1 mg/day intraventricularly.
It is well documented that the action of gentamicin is particularly susceptible to changes in the salt concentration of the medium (Rubenis et al, 1963; Schoutens and Yourassowsky, 1972) . When it is necessary to assay the drug in body fluids this is usually done against reference standards which are made up in the same fluid in order to minimize any discrepancies due to variation in the constituents of the medium. However, this principle appears to have been neglected in assays of gentamicin in CSF, probably due, at least in part, to the fact that pooled human CSF is not readily available in many laboratories.
Received for publication 20 January 1976 Reported levels of gentamicin in the CSF are often the result of assays against reference standards made up in water (Newman and Holt, 1967 procedure as above except that the assay medium was supplemented with 0 5 % NaCI. The difference in the curves from standards made up in water and in CSF is reduced to a factor of about 1P5. Both the curves from standards made up in 159 mM NaCI and in 150 mM NaCl/4-5 mM CaCI2 correlate well with the CSF curve.
Results are shown for a single experiment but this was repeated four times. In the unsupplemented medium the CSF curve always differed from the distilled water curve by a factor greater than 3. When the medium was supplemented with 05% NaCl the difference always exceeded a factor of 1-3. These results were still reproducible when different batches of pooled CSF were used.
To test for protein binding 0-2 ml of 14C-gentamicin was added to 0 8 ml pooled human CSF to give a final concentration of 100 mg free base/l. 0-2 ml of 14C-gentamicin was also added to 0- 
Discussion
These results further emphasize theneedfor standardization in antibiotic assays. Gentamicin levels reported using reference standards made up in water may be four times as high as the actual levels. Thus, a level which appears to be above the MIC for the infecting organism may well be subtherapeutic.
To date there have been no reports of toxic effects due to intrathecal or intraventricular administration of gentamicin. However, since a large number of cases described have involved neonates, there probably has not been sufficient follow-up completely to rule out this possiblity. It is also important therefore that assays are carried out accuratelytoensure that potentially toxic levels are not reached. A level reported as being safe by one assay method could be toxic when assayed by a different method.
The salt solutions were prepared to correspond with the ionic strength of CSF. In salt-free medium the curves obtained from standards made up in 150 mM NaCI/4 5 CaCl2 and 159 mM NaCI differed despite these solutions having the same ionic strength. This supports the theory that the effect of divalent cations such as Mg2+ and Ca2+ on the action of gentamicin is not solely related to their influence on the ionic strength of the medium (Gilbert et al, 1971) . It is not certain why this effect of calcium ions is not apparent when the medium is supplemented with 0 5 % NaCl.
There is also an increase in the range of zone diameters in the presence of 0.5% NaCl, and I have discussed this elsewhere (Deacon, 1976) .
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There was no association of gentamicin with CSF proteins in the specimen tested, which at 890 mg protein/l had a protein concentration considerably higher than normal. However, in bacterial meningitis the protein content of the CSF may increase to 10 g or more per litre and it is not known whether such high levels would affect protein-binding of the drug.
It is clear from these results that gentamicin in CSF should not be assayed against reference standards made up in water. If pooled CSF is not available then 150 mM NaCl/4 5 mM CaCI2 would seem to be an adequate substitute.
I am grateful to Dr R. E. M. Thompson for helpful advice in the preparation of this paper and to Miss Susan Lockwood for typing the manuscript.
The radioactive gentamicin was a gift from Nicholas Laboratories.
